In spring 2020, Jazzminn Hein received an automated phone call from The Ottawa Hospital in Canada, asking if she or anyone in her household had experienced wheezing, shortness of breath or other breathing problems in recent months. The question caught her attention: Just a week earlier, Ms. Hein, then 24, had gone on a stroll…
The New York attorney general on Thursday urged the Food and Drug Administration to “take immediate action” and renew alerts to doctors and patients about the dangerous effects of Singulair for children, saying that the current warnings about the drug’s psychiatric side effects were not sufficient. In a letter, the attorney general, Letitia James, also…
In early 2020, the Food and Drug Administration responded to decades of escalating concerns about a commonly prescribed drug for asthma and allergies by deploying one of its most potent tools: a stark warning on the drug’s label that it could cause aggression, agitation and even suicidal thoughts. The agency’s label, which was primarily aimed…
